Estrogen protects against oxidative multiorgan damage in rats with chronic renal failure

Renal Failure

Volumn 31, Issue 8, 2009, Pages 711-725

  Kasimay, Özgür ^a   Şener, Göksel ^a   Çakir, Bariş ^a   Yüksel, Meral ^b   Çetinel, Şule ^c   Contuk, Gazi ^c   Yeǧen, Berrak Ç ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b Vocational School of Health Related Professions   (Turkey)

^c MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Chronic renal failure; Estradiol; Lipid peroxidation; Myeloperoxidase; TNF alpha

Indexed keywords

COLLAGEN; CREATININE; ESTRADIOL PROPIONATE; GLUTATHIONE; LUCIGENIN; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG ACTIVITY; FEMALE; MALE; MULTIPLE ORGAN FAILURE; NEPHRECTOMY; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; ESTRADIOL; FEMALE; KIDNEY FAILURE, CHRONIC; MULTIPLE ORGAN FAILURE; NEPHRECTOMY; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 70350664474     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/08860220903134563     Document Type: Article

References (66)

1. Cottone S, Lorito MC, Riccobene R, Nardi E, Mulè G, Buscemi S, Geraci C, Guarneri M, Arsena R, Cerasola G. Oxidative stress, inflammation and cardiovascular disease in chronic renal failure. J Nephrol. 2008;21:175-179.
2. Siems W, Quast S, Carluccio F, Wiswedel I, Hirsch D, Augustin W, Hampi H, Riehle M, Sommerburg O. Oxidative stress in chronic renal failure as a cardiovascular risk factor. Clin Nephrol. 2002;58 (Suppl. 1):S12-S19.
3. Sener G, Paskaloglu K, Satiroglu H, Alican I, Kaçmaz A, Sakarcan A. L-carnitine ameliorates oxidative damage due to chronic renal failure in rats. J Cardiovasc Pharmacol. 2004; 43:698-705. (Pubitemid 38534071)
4. Silbiger S, Neugarten J. Gender and human chronic renal disease. Gend Med. 2008;5 (Suppl. A):S3-S10.
5. Seliger SL, Davis C, Stehman-Breen C. Gender and the progression of renal disease. Curr Opin Nephrol Hypertens. 2001;10:219-225.
6. Neugarten J. Gender and the progression of renal disease. J Am Soc Nephrol. 2002;13:2807-2809.
7. Schulman IH, Aranda P, Raij L, Veronesi M, Aranda FJ, Martin R.. Surgical menopause increases salt sensitivity of blood pressure. Hypertension. 2006;47:1168-1174.
8. Reckelhoff JF, Zhang H, Srivastava K, Granger JP. Gender differences in hypertension in spontaneously hypertensive rats: Role of androgens and androgen receptor. Hypertension. 1999;34:920-923.
9. Baylis C. Sexual dimorphism of the aging kidney: Role of nitric oxide deficiency. Physiology (Bethesda). 2008;23: 142-150.
10. Irwin RW, Yao J, Hamilton RT, Cadenas E, Brinton RD, Nilsen J. Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. Endocrinology. 2008; 149:3167-3175.
11. Gragasin FS, Xu Y, Arenas IA, Kainth N, Davidge ST. Estrogen reduces angiotensin II-induced nitric oxide synthase and NAD(P)H oxidase expression in endothelial cells. Arterioscler Thromb Vasc Biol. 2003;23:38-44.
12. Strehlow K, Rotter S, Wassmann S, Adam O, Grohe C, Laufs K, Bohm M, Nickenig G. Modulation of antioxidant enzyme expression and function by estrogen. Circ Res. 2003; 93:170-177.
13. Sugioka K, Shimosegawa Y, Nakano M. Estrogens as natural antioxidants of membrane phospholipid peroxidation. FEBS Lett. 1987;210:37-39.
14. Green PS, Gordon K, Simpkins JW. Phenolic A ring requirement for the neuroprotective effects of steroids. J Steroid Biochem Mol Biol. 1997;63:229-235.
15. Zhai P, Eurell TE, Cotthaus R, Jeffery EH, Bahr JM, Gross DR. Effect of estrogen on global myocardial ischemiareperfusion injury in female rats. Am J Physiol Heart Circ Physiol. 2000;279:H2766-H2775.
16. Behl C. Oestrogen as a neuroprotective hormone. Nat Rev Neurosci. 2002;3:433-442.
17. Feng Z, Zhang JT. Long-term melatonin or 17beta-estradiol supplementation alleviates oxidative stress in ovariectomized adult rats. Free Radic Biol Med. 2005;39:195-204.
18. Lee MY, Jung SC, Lee JH, Han HJ. Estradiol-17beta protects against hypoxia-induced hepatocyte injury through ER-mediated upregulation of Bcl-2 as well as ER-independent antioxidant effects. Cell Res. 2008;18:491-499.
19. Persky AM, Green PS, Stubley L, Howell CO, Zaulyanov L, Brazeau GA, Simpkins JW. Protective effect of estrogens against oxidative damage to heart and skeletal muscle in vivo and in vitro. Proc Soc Exp Biol Med. 2000;223:59-66.
20. Sener G, Arbak S, Kurtaran P, Gedik N, Yegen BC. Estrogen protects the liver and intestines against sepsis-induced injury in rats. J Surg Res. 2005;128(1):70-78.
21. Günal O, Oktar BK, Ozçinar E, Sungur M, Arbak S, Yegen B. Estradiol treatment ameliorates acetic acid-induced gastric and colonic injuries in rats. Inflammation. 2003;27:351-359.
22. Ozveri ES, Bozkurt A, Haklar G, Cetinel S, Arbak S, Yegen C, Yegen BC. Estrogens ameliorate remote organ inflammation induced by burn injury in rats. Inflamm Res. 2001;50:585-591.
23. Vaziri ND, Ni Z, Oveisi F, Liang K, Pandian R. Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension 2002; 39:135-141.
24. Talke H, Schubert GE. Enzymatic urea determination in the blood and serum in the Warburg optical test. Wiener Klinische Wochenschrift. 1965;43:174-175.
25. Slot C. Plasma creatinine determination: A new and specific Jaffe reaction method. Scand J Clin Lab Invest. 1965;17: 381-387.
26. Beuge JA, Aust SD. Microsomal lipid peroxidation. Methods in Enzymology. 1978;52:302-311.
27. Beutler E. Glutathione. In Beutler E (ed.). Red blood cell metabolism: A manual of biochemical methods. New York: Grune & Stratton;1975:112-114.
28. Bradley PP, Priebat DA, Christersen RD, Rothstein G. Measurement of cutaneous inflammation. Estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78:206-209.
29. Hillegass LM, Griswold DE, Brickson B, Albrightson- Winslow C. Assessment of myeloperoxidase activity in whole rat kidney. J Pharm Methods. 1990;24:285-295.
30. Haklar G, Ulukaya-Durakbasa C, Yüksel M, Dagli T, Yalcin AS. Oxygen radicals and nitric oxide in rat mesenteric ischemia-reperfusion: Modulation by L-arginine and N-nitro-L-arginine methyl ester. Clin Exp Pharmacol Physiol. 1998;25:908-912.
31. Lopez De Leon A, Rojkind M. A simple micromethod for collagen and total protein determination in formalin-fixed parraffin-embedded sections. J Histochem Cytochem. 1985; 33:737-743.
32. Tozawa M, Iseki K, Iseki C, Kinjo K, Ikemiya Y, Takishita S. Blood pressure predicts risk of developing end-stage renal disease in men and women. Hypertension. 2003;41:1341-1345.
33. Neugarten J. Gender and the progression of renal disease. J Am Soc Nephrol. 2002;13:2807-2809.
34. Ball P, Emons G, Kayser H, Teichmann J. Metabolic clearance rates of catechol estrogens in rats. Endocrinology. 1983; 113:1781-1783.
35. Schulman IH, Aranda P, Raij L, Veronesi M, Aranda FJ, Martin R. Surgical menopause increases salt sensitivity of blood pressure. Hypertension. 2006;47:1168-1174.
36. Reckelhoff JF, Zhang H, Srivastava K, Granger JP. Gender differences in hypertension in spontaneously hypertensive rats: Role of androgens and androgen receptor. Hypertension. 1999;34:920-923.
37. Park KM, Kim JI, Ahn Y, Bonventre AJ, Bonventre JV. Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury. J Biol Chem. 2004;279: 52282-52292.
38. Müller V, Losonczy G, Heemann U, Vannay A, Fekete A, Reusz G, Tulassay T, Szabó AJ. Sexual dimorphism in renal ischemia-reperfusion injury in rats: Possible role of endothelin. Kidney Int. 2002;62:1364-1371.
39. Fekete A, Vannay A, Ver A, et al. Sex differences in the alterations of Na(+), K(+)-ATPase following ischaemia- reperfusion injury in the rat kidney. J Physiol. 2004;555: 471-480.
40. Barp J, Araujo ASR, Fernandes TR, et al. Myocardial antioxidant and oxidative stres changes due to sex hormones. Braz J Med Biol Res. 2002;35:1075-1081.
41. Dubey RK, Tyurina YY, Tyurin VA, et al. Estrogen and tamoxifen metabolites protect smooth muscle cell membrane phospholipids against peroxidation and inhibit cell growth. Circ Res. 1999;84:229-239.
42. Hamden K, Carreau S, Ellouz F, Masmoudi H, El FA. Protective effect of 17beta-estradiol on oxidative stress and liver dysfunction in aged male rats. J Physiol Biochem. 2007;63: 195-201.
43. Chiang K, Parthasarathy S, Santanam N. Estrogen, neutrophils and oxidation. Life Sci. 2004;75:2425-2438.
44. Chang SP, Yang WS, Lee SK, Min WK, Park JS, Kim SB. Effects of hormonal replacement therapy on oxidative stress and total antioxidant capacity in postmenopausal hemodialysis patients. Ren Fail. 2002;24:49-57.
45. Stringer KD, Komers R, Osman SA, Oyama TT, Lindsley JN, Anderson S. Gender hormones and the progression of experimental polycystic kidney disease. Kidney Int. 2005;68(4): 1729-1739.
46. Maric C, Xu Q, Sandberg K, Hinojosa-Laborde C. Agerelated renal disease in female dahl salt-sensitive rats is attenuated with 17b-estradiol supplementation by modulating nitric oxide synthase expression. Gend Med. 2008;5: 147-159.
47. Westhuyzen J, Adams CE, Fleming SJ. Evidence for oxidative stress during in vitro dialysis. Nephron. 1995;70:49-54.
48. Kettle AJ, Winterbourn CC. Myeloperoxidase: A key regulator of neutrophil oxidant production. Redox Rep. 1997; 3:3-15.
49. Sener G, Sakarcan A, Sehirli O, Eksioglu-Demiralp E, Sener E, Ercan F, Gedik N, Yegen BC. Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast. Prostaglandins and Other Lipid Mediators. 2007;83:257-267. (Pubitemid 46710463)
50. Lim CS, Vaziri ND. Iron and oxidative stress in renal insufficiency. Am J Nephrol. 2004;24:569-575.
51. Faas MM, Bakker WW, Valkhof N, Schuiling GA. Effect of estradiol and progesterone on the low-dose endotoxin-induced glomerular inflammatory response of the female rat. Am J Reprod Immunol. 1999;41:224-231.
52. Baud L, Ardaillou R. Tumor necrosis factor in renal injury. Miner Electrolyte Metab. 1995;21:336-341.
53. Guarnieri G, Antonione R, Biolo G. Mechanisms of malnutrition in uremia. J Ren Nutr. 2003;13:153-157.
54. Cau J, Favreau F, Zhang K. FR167653 improves renal recovery and decreases inflammation and fibrosis after renal ischemia reperfusion injury. J Vasc Surg. 2009;49: 728-740.
55. Hsieh CH, Nickel EA, Chen J, Schwacha MG, Choudhry MA, Bland KI, Chaudry IH. Mechanism of the salutary effects of estrogen on kupffer cell phagocytic capacity following trauma-hemorrhage: Pivotal role of Akt activation. J Immunol. 2009;182:4406-4414.
56. Huang H, He J, Yuan Y, Aoyagi E, Takenaka H, Itagaki T, Sannomiya K, Tamaki K, Harada N, Shono M, Shimizu I, Takayama T. Opposing effects of estradiol and progesterone on the oxidative stress-induced production of chemokine and proinflammatory cytokines in murine peritoneal macrophages. J Med Invest. 2008;55:133-141.
57. Borrás C, Sastre J, García-Sala D, Lloret A, Pallardó FV, Viña J. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic Biol Med. 2003;34:546-552.
58. Sener G, Paskaloglu K, Toklu H, Kapucu C, Ayanoglu- Dulger G, Kacmaz A, Sakarcan A. Melatonin ameliorates chronic renal failure-induced oxidative organ damage in rats. J Pineal Res. 2004;36:232-241. (Pubitemid 38530470)
59. Calunga JL, Zamora ZB, Borrego A, Río S, Barber E, Menéndez S, Hernández F, Montero T, Taboada D. Ozone therapy on rats submitted to subtotal nephrectomy: Role of antioxidant system. Mediators Inflamm. 2005;2005:221-227.
60. Ceballos-Picot I, Witko-Sarsat V, Merad-Boudia M, Nguyen AT, Thévenin M, Jaudon MC, Zingraff J, Verger C, Jungers P, Descamps-Latscha B. Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic Biol Med. 1996;21:845-853.
61. Himmelfarb J, McMenamin E, McMonagle E. Plasma aminothiol oxidation in chronic hemodialysis patients. Kidney Int. 2002;61:705-716.
62. Guccione M, Silbiger S, Lei J, Neugarten J. Estradiol upregulates mesangial cell MMP-2 activity via the transcription factor AP-2. Am J Physiol Renal Physiol. 2002;282:F164-F169.
63. Potier M, Elliot SJ, Tack I, et al. Expression and regulation of estrogen receptors in mesangial cells: Influence on matrix metalloproteinase-9. J Am Soc Nephrol. 2001;12:241-251.
64. Neugarten J, Acharya A, Lei J, Silbiger S. Selective estrogen receptor modulators suppress mesangial cell collagen synthesis. Am J Physiol Renal Physiol. 2000;279:F309-F318.
65. Zdunek M, Silbiger S, Lei J, Neugarten J. Protein kinase CK2 mediates TGF-b1-stimulated type IV collagen gene transcription and its reversal by estradiol. Kidney Int. 2001; 60:2097-2108.
66. Blush J, Lei J, Ju W, Silbiger S, Pullman J, Neugarten J. Estradiol reverses renal injury in Alb/TGF-b1 transgenic mice. Kidney Int. 2004;66:2148-2154.